Venous Thromboembolism Risk With Orthopedic Surgery in Thrombophilia
Patients with thrombophilia demonstrate an elevated risk for venous thromboembolism after undergoing orthopedic surgery.
Thromboembolism
Venous Thromboembolism Risk Steadily Increasing in Cancer
The risk for venous thromboembolism is steadily increasing among patients with cancer compared with the general population.
Venous Thromboembolism Rates in Patients With SARS-CoV-2 Infection
In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.
Notable Variation Exists in the Treatment of Serious VTE Events in Pediatric Leukemia
There might be notable variations among hematology, oncology, and bone marrow transplant practitioners when treating thrombotic events in children with leukemia.
ASH 2020 Guidelines on Venous Thromboembolism Management
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
Surgical Splenectomy May Increase Risk for Venous Thromboembolism in Sickle Cell Disease
Patients with sickle cell disease may have an increased risk for venous thromboembolic events, especially pulmonary embolism, following surgical splenectomy.
Overuse of Unfractionated Heparin in Hospitalized Patient With Venous Thromboembolism
Despite existing guidelines, patients with first-time acute DVT or PE were administered unfractionated heparin more frequently than LMWH.
Rivaroxaban May Be a Suitable Alternative to Low-Molecular Weight Heparin in Cancer-Associated Thrombosis
Among some patients with cancer-associated thrombosis, rivaroxaban may be a viable alternative to low-molecular-weight heparin.
Molecular Profiling Can Assess Risk for Myeloproliferative Neoplasms With Splanchnic Vein Thrombosis
Researchers sought to markers that could identify high risk for splanchnic vein thrombosis among patients with MPNs.
Factor V Activity Associated With Clinical Outcomes in Severe COVID-19
Investigators assess underlying mechanisms and relevant biomarkers of morbidity and mortality due to coagulopathy in patients with severe COVID-19 infection.
-
Loading...
-
Loading...
Next post in Thrombotic Disorders
